Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |